1. An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool. Issue 31 (18th July 2019) Authors: Bellan, Steven E.; Eggo, Rosalind M.; Gsell, Pierre-Stéphane; Kucharski, Adam J.; Dean, Natalie E.; Donohue, Richard; Zook, Matt; Edmunds, W. John; Odhiambo, Frank; Longini, Ira M.; Brisson, Marc; Mahon, Barbara E.; Henao-Restrepo, Ana Maria Journal: Vaccine Issue: Volume 37:Issue 31(2019) Page Start: 4376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anal human papillomavirus prevalence and risk factors among men who have sex with men in Vietnam. (November 2021) Authors: Tuan, Le Anh; Prem, Kiesha; Pham, Quang Duy; Toh, Zheng Quan; Tran, Hau Phuc; Nguyen, Phuc Duy; Mai, Chu Thi Ngoc; Ly, Le Thi Khanh; Cao, Van; Le-Ha, Tam-Duong; Tuan, Nguyen Anh; Jit, Mark; Bright, Kathryn; Brisson, Marc; Nguyen, Thuong Vu; Garland, Suzanne; Anh, Dang Duc; Trang, Nguyen Van; Mulh... Journal: International journal of infectious diseases Issue: Volume 112(2021) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study. Issue 12 (2nd December 2019) Authors: Bolotin, Shelly; Severini, Alberto; Hatchette, Todd; McLachlan, Elizabeth; Savage, Rachel; Hughes, Stephanie L.; Wang, John; Deeks, Shelley L.; Wilson, Sarah; Brisson, Marc; Halperin, Scott A.; Gubbay, Jonathan; Mazzulli, Tony; Serhir, Bouchra; Ward, Brian J.; Crowcroft, Natasha Journal: Human vaccines & immunotherapeutics Issue: Volume 15:Issue 12(2019) Page Start: 2856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada. Issue 16 (7th April 2016) Authors: Drolet, Melanie; Deeks, Shelley L.; Kliewer, Erich; Musto, Grace; Lambert, Pascal; Brisson, Marc Journal: Vaccine Issue: Volume 34:Issue 16(2016) Page Start: 1874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model. (6th January 2015) Authors: Jit, Mark; Brisson, Marc; Laprise, Jean-François; Choi, Yoon Hong Journal: BMJ Issue: Volume 350(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule. Issue 6 (5th February 2021) Authors: Whitworth, Hilary S.; Schiller, John; Markowitz, Lauri E.; Jit, Mark; Brisson, Marc; Simpson, Evan; Watson-Jones, Deborah Journal: Vaccine Issue: Volume 39:Issue 6(2021) Page Start: 871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. (December 2016) Authors: Simms, Kate T; Laprise, Jean-François; Smith, Megan A; Lew, Jie-Bin; Caruana, Michael; Brisson, Marc; Canfell, Karen Journal: Lancet Issue: Volume 1:Number 2(2016) Page Start: e66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11. Issue 1 (5th October 2010) Authors: Brisson, Marc; Van de Velde, Nicolas; Boily, Marie-Claude Journal: Sexually transmitted infections Issue: Volume 87:Issue 1(2011) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study. Issue 4 (April 2020) Authors: Abbas, Kaja M; van Zandvoort, Kevin; Brisson, Marc; Jit, Mark Journal: Lancet Issue: Volume 8:Issue 4(2020) Page Start: e536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Issue 6 (5th February 2020) Authors: Whitworth, Hilary S.; Gallagher, Katherine E.; Howard, Natasha; Mounier-Jack, Sandra; Mbwanji, Gladys; Kreimer, Aimée R.; Basu, Partha; Kelly, Helen; Drolet, Mélanie; Brisson, Marc; Watson-Jones, Deborah Journal: Vaccine Issue: Volume 38:Issue 6(2020) Page Start: 1302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗